The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Histogen Inc(NASDAQ:HSTO) 
Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopeci...
Website: https://www.conatuspharma.com/
Founded: 2005
Full Time Employees: 22
CEO: Steven Mento
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Histogen Days Payable Outstanding ttm (DPO)
Histogen Days Receivable Outstanding ttm (DSO)
Histogen Days Inventory Outstanding ttm (DIO)
Histogen Op Cashflow Per Share ttm
Histogen Free Cashflow Per Share ttm
Histogen Cash Per Share ttm
Histogen P/S ratio ttm
Histogen (GAAP) P/E ratio ttm
Histogen P/B ratio ttm
No extra charts and metrics for this ticker.